Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients

Panagiotis I Georgianos1, Pantelis A Sarafidis, Anastasios N Lasaridis

  • 1Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA University Hospital, St. Kiriakidi 1, GR54636, Thessaloniki, Greece. pangeorgi@yahoo.gr.

Insights

Arterial stiffness predicts cardiovascular disease and mortality in chronic kidney disease (CKD) patients. Targeting arterial hardening may reduce cardiovascular risk in these individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Arterial stiffness is a significant predictor of cardiovascular disease (CVD) and mortality in patients with chronic kidney disease (CKD).
  • Evidence suggests arterial hardening is linked to adverse outcomes across various CKD stages, including hemodialysis, peritoneal dialysis, and transplant recipients.
  • The dissociation of arterial stiffness from blood pressure reduction indicates it may be a modifiable risk factor, not just a predictor.

Purpose of the Study:

  • To summarize clinical and epidemiological evidence on the prognostic significance of arterial stiffness in CKD.
  • To explore arterial stiffness as a therapeutic target for cardiovascular risk reduction in CKD patients.
  • To provide insights into potential treatment strategies for attenuating arterial stiffness.

Main Methods:

  • Review of prospective observational studies and clinical/epidemiological data.
  • Analysis of the relationship between arterial stiffness and cardiovascular outcomes in CKD populations.
  • Synthesis of evidence regarding interventions targeting arterial stiffness.

Main Results:

  • Arterial stiffness is a strong, independent predictor of CVD and mortality in hemodialysis patients.
  • Arterial hardening predicts cardiovascular and all-cause mortality in peritoneal dialysis patients, renal transplant recipients, and non-dialysis CKD patients.
  • Arterial stiffness may represent a reversible arterial remodeling pattern and a true risk factor in CKD.

Conclusions:

  • Arterial stiffness is a crucial prognostic marker for cardiovascular events in CKD.
  • Targeting arterial stiffness presents a novel therapeutic strategy for cardiovascular risk reduction in CKD.
  • Interventions like RAS blockade, statins, and phosphate control may mitigate arteriosclerosis progression.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...